PubMed:23194825
Annnotations
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_23194825_3_0 | 414-430 | expanded | denotes | α-methyldopamine |
| SS2_23194825_3_0 | 432-438 | abbr | denotes | α-MeDA |
| SS1_23194825_3_1 | 444-469 | expanded | denotes | N-methyl-α-methyldopamine |
| SS2_23194825_3_1 | 471-482 | abbr | denotes | N-Me-α-MeDA |
| SS1_23194825_7_0 | 1009-1025 | expanded | denotes | N-acetylcysteine |
| SS2_23194825_7_0 | 1027-1030 | abbr | denotes | NAC |
| SS1_23194825_8_0 | 1182-1190 | expanded | denotes | dopamine |
| SS2_23194825_8_0 | 1192-1194 | abbr | denotes | DA |
| SS1_23194825_9_0 | 1420-1449 | expanded | denotes | γ-glutamylcysteine synthetase |
| SS2_23194825_9_0 | 1451-1456 | abbr | denotes | γ-GCS |
| SS1_23194825_10_0 | 1530-1552 | expanded | denotes | buthionine sulfoximine |
| SS2_23194825_10_0 | 1554-1557 | abbr | denotes | BSO |
| AE1_23194825_3_0 | SS1_23194825_3_0 | SS2_23194825_3_0 | abbreviatedTo | α-methyldopamine,α-MeDA |
| AE1_23194825_3_1 | SS1_23194825_3_1 | SS2_23194825_3_1 | abbreviatedTo | N-methyl-α-methyldopamine,N-Me-α-MeDA |
| AE1_23194825_7_0 | SS1_23194825_7_0 | SS2_23194825_7_0 | abbreviatedTo | N-acetylcysteine,NAC |
| AE1_23194825_8_0 | SS1_23194825_8_0 | SS2_23194825_8_0 | abbreviatedTo | dopamine,DA |
| AE1_23194825_9_0 | SS1_23194825_9_0 | SS2_23194825_9_0 | abbreviatedTo | γ-glutamylcysteine synthetase,γ-GCS |
| AE1_23194825_10_0 | SS1_23194825_10_0 | SS2_23194825_10_0 | abbreviatedTo | buthionine sulfoximine,BSO |
CHEMDNER-training-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 100-107 | TRIVIAL | denotes | Ecstasy |
| T2 | 110-143 | SYSTEMATIC | denotes | 3,4-methylenedioxymethamphetamine |
| T3 | 147-151 | ABBREVIATION | denotes | MDMA |
| T4 | 273-277 | ABBREVIATION | denotes | MDMA |
| T5 | 320-324 | ABBREVIATION | denotes | MDMA |
| T6 | 379-383 | ABBREVIATION | denotes | MDMA |
| T7 | 392-400 | TRIVIAL | denotes | catechol |
| T8 | 414-430 | SYSTEMATIC | denotes | α-methyldopamine |
| T9 | 432-438 | ABBREVIATION | denotes | α-MeDA |
| T10 | 444-469 | SYSTEMATIC | denotes | N-methyl-α-methyldopamine |
| T11 | 471-482 | ABBREVIATION | denotes | N-Me-α-MeDA |
| T12 | 540-553 | TRIVIAL | denotes | retinoic acid |
| T13 | 558-595 | SYSTEMATIC | denotes | 12-O-tetradecanoyl-phorbol-13-acetate |
| T14 | 670-678 | TRIVIAL | denotes | dopamine |
| T15 | 709-717 | TRIVIAL | denotes | dopamine |
| T16 | 733-737 | ABBREVIATION | denotes | MDMA |
| T17 | 738-746 | TRIVIAL | denotes | catechol |
| T18 | 886-890 | ABBREVIATION | denotes | MDMA |
| T19 | 986-997 | TRIVIAL | denotes | glutathione |
| T20 | 1009-1025 | SYSTEMATIC | denotes | N-acetylcysteine |
| T21 | 1027-1030 | ABBREVIATION | denotes | NAC |
| T22 | 1075-1079 | ABBREVIATION | denotes | MDMA |
| T23 | 1120-1130 | TRIVIAL | denotes | superoxide |
| T24 | 1182-1190 | TRIVIAL | denotes | dopamine |
| T25 | 1209-1218 | IDENTIFIER | denotes | GBR 12909 |
| T26 | 1274-1280 | ABBREVIATION | denotes | α-MeDA |
| T27 | 1317-1328 | TRIVIAL | denotes | glutathione |
| T28 | 1330-1333 | ABBREVIATION | denotes | GSH |
| T29 | 1420-1438 | SYSTEMATIC | denotes | γ-glutamylcysteine |
| T30 | 1530-1552 | SYSTEMATIC | denotes | buthionine sulfoximine |
| T31 | 1554-1557 | ABBREVIATION | denotes | BSO |
| T32 | 1593-1599 | ABBREVIATION | denotes | α-MeDA |
| T33 | 1620-1623 | ABBREVIATION | denotes | GSH |
| T34 | 1691-1694 | ABBREVIATION | denotes | BSO |
| T35 | 1719-1722 | ABBREVIATION | denotes | NAC |
| T36 | 1750-1756 | ABBREVIATION | denotes | α-MeDA |
| T37 | 1811-1814 | ABBREVIATION | denotes | GSH |
| T38 | 1873-1876 | ABBREVIATION | denotes | BSO |
| T39 | 1887-1898 | ABBREVIATION | denotes | N-Me-α-MeDA |
| T40 | 1949-1952 | ABBREVIATION | denotes | NAC |
| T41 | 1985-1989 | ABBREVIATION | denotes | MDMA |
| T42 | 1990-1998 | TRIVIAL | denotes | catechol |
| T1 | 18-25 | TRIVIAL | denotes | ecstasy |